- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01280773
Effect of NAVA on Weaning Duration in Difficult to Wean Patients
October 12, 2018 updated by: Ling Liu
Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China; Department of Critical Care Medicine St. Michaels's Hospital, University of Toronto, Canada
It has been showed that over assist and patient ventilator asynchrony often occur in mechanical ventilated patients, especially in patients who failed weaning, which are associated with a prolonged duration of mechanical ventilation.Neurally adjusted ventilatory assist (NAVA) improves patient-ventilator synchrony, prevents excessive assist induced diaphragm inactivation.
So the aim of this study was to detect that whether NAVA compared with PSV has the ability to reduce the duration of weaning in difficult to wean patients.
Study Overview
Detailed Description
Intubated patients who were deemed ready for weaning by the clinical team but failed the first spontaneous breathing trials (SBT) or weaning were screened for eligibility.
After enrollment, nasogastric tube eligible patient was replaced with a modified EAdi catheter.
Then the patients were switched to a Servo-i ventilator.
According to a random digits table, eligible patients were allocated randomly to ventilation with NAVA or pressure support ventilation (PSV).
In PSV group, ventilator settings were determined by the physicians who in charge of the patients, and EAdi signals were not available for ventilator settings.
In NAVA group, a daily NAVA level titration was performed to select the NAVA level which got approximate 50% unload, if the patients can't tolerate PSV or NAVA, PCV should be used to insure the ventilation safety.
If the patients were under PCV mode, screening should be done by the researchers every 3 hours to make sure whether they will tolerate PSV or NAVA.
In both group, daily measurement of diaphragmatic function was performed (only preformed in the first 10 patients of each group), followed by a 30 minutes SBT with PSV 5-7 cmH2O.
Patients who were able to tolerate the SBT were extubated.
Patients who completed the SBT and remained extubated > 48 h were considered successfully extubated.
Patients who failed SBT, or required noninvasive ventilation (NIV), or were re-intubated, or deceased within 48h post-extubation were considered extubation failure.
Local sedation protocol including daily wakeup was performed during the research period.
All continuous sedative infusions were discontinued at least 1 hour before the measurement of diaphragmatic function and SBT.
Main end point was the duration of weaning, and second end point was extubation rate, diaphragmatic function and patient ventilator asynchrony.
Study Type
Interventional
Enrollment (Actual)
99
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210009
- Nanjing Zhong-Da Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Intubated patients who were deemed ready for weaning by the clinical team but failed the first spontaneous breathing trials (SBT) or weaning
Exclusion Criteria:
- age <18 or >80 years,
- tracheostomy
- treatment abandonment
- history of esophageal varices
- gastro-esophageal surgery in the previous 12 months or gastro-esophageal bleeding in the previous 30 days
- coagulation disorders (INR ratio>1.5 and APTT>44 s)
- history of acute central or peripheral nervous system disorder or severe neuromuscular disease
- history of leukemia, severe chronic liver or chronic cardiac disease
- solid organ transplantation
- malignant tumor.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: PSV weaning
Patinens in the PSV group will be weaned using PSV mode.
|
|
|
Experimental: NAVA weaning
Patients in NAVA group will eb weaned using NAVA mode.
|
Neurally adjusted ventilatory assist (NAVA) was delivered by a SVi ventilator.
NAVA utilizes EAdi, a reflection of the neural respiratory output to diaphragm, as its primary source to trigger and cycle-off assist in synchrony with neural inspiratory efforts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of weaning
Time Frame: 48h after extubation
|
Duration of weaning was defined as time from study enrollment to extubation.
|
48h after extubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Extubation rate
Time Frame: 48h after extubation or 30 day after enrollment
|
Extubation rate was defined as the percentage of patients with successful weaning
|
48h after extubation or 30 day after enrollment
|
|
diaphragmatic function
Time Frame: At 8 am daily before extubatiuon
|
Diaphragmatic function was measured by neuro-ventilatory efficiency (NVE), a ratio of tidal volume to diaphragm electrical activity (Vt/EAdi), and neuro-mechanical efficiency (NME), a ratio of airway pressure to EAdi(Paw/EAdi) during airway occlusion.
diaphragmatic function
|
At 8 am daily before extubatiuon
|
|
Patient ventilator asynchrony
Time Frame: At 8 am daily until extubation
|
Time delay between neuro inspiration and ventilator delivery.
Time delay between neuro expiration and ventilator cycle-off.
|
At 8 am daily until extubation
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: ICU or hospital discharge or 28day
|
ICU, 28 day and hospital mortality
|
ICU or hospital discharge or 28day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Haibo Qiu, PhD,MD, Southeast university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2011
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
October 1, 2018
Study Registration Dates
First Submitted
December 28, 2010
First Submitted That Met QC Criteria
January 19, 2011
First Posted (Estimate)
January 21, 2011
Study Record Updates
Last Update Posted (Actual)
October 16, 2018
Last Update Submitted That Met QC Criteria
October 12, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 437129518
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weaning
-
National Cancer Institute, EgyptCompletedWeaning Failure | Successful WeaningEgypt
-
Hospital do CoracaoNot yet recruitingWeaning Failure | Weaning From Mechanical Ventilation | Weaning From Mechanical Ventilation, Extubation
-
Cairo UniversityCompletedWeaning Failure | Weaning From Mechanical Ventilation | Mechanical VentilationEgypt
-
Università degli Studi di FerraraCompletedWeaning Failure | Mechanical Ventilation WeaningItaly
-
Central Hospital, Nancy, FranceCentre Hospitalier Régional Metz-ThionvilleNot yet recruitingHypnosis | Weaning Mechanical Ventilation | Hypnosis During Weaning From Invasive Mechanical VentilationFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Federico II UniversityCompleted
-
Queen's University, BelfastUniversity College, London; University of Leeds; University of Edinburgh; Royal... and other collaboratorsCompletedVentilator WeaningUnited Kingdom
-
Ain Shams UniversityUnknown
Clinical Trials on NAVA
-
Centre Hospitalier Intercommunal CreteilCompletedPremature Birth | Ventilator Lung; NewbornFrance
-
King's College Hospital NHS TrustKing's College London; Guy's and St Thomas' NHS Foundation Trust; National Institute... and other collaboratorsCompletedAdults With Cardiopulmonary Disease at Risk of Prolonged Weaning From Mechanical VentilationUnited Kingdom
-
University of Sao Paulo General HospitalCompletedRespiratory FailureBrazil
-
Sahlgrenska University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University Hospital, CaenCompletedAcute Lung Injury | Mechanical VentilationFrance
-
University of PadovaRecruitingVentilator-Induced Lung Injury | Lung Transplantation | Work of Breathing | Neurally Adjusted Ventilatory Assist | Acute Respiratory Failure (ARF)Italy
-
University of FloridaCompletedPreterm Infant | Barotrauma | BPD - Bronchopulmonary DysplasiaUnited States
-
ProMedica Health SystemCompletedOther Specified Respiratory Problems in Fetus or NeonateUnited States
-
Julie LefevereCompletedNewborn MorbidityBelgium